Anna Traczyk

Anna Traczyk is a Senior Scientist at Illumina since July 2021, with prior experience as a Scientist at the Genome Institute of Singapore, where research focused on the immunogenicity of gene therapy methods, specifically CRISPR/Cas9. Anna has held various roles, including Team Lead at Stronghold Diagnostics Lab, contributing to the establishment of a COVID-19 diagnostic lab, and a Postdoctoral Fellow, where innovative methodologies were developed for testing immunogenicity. Educational qualifications include a Ph.D. in Biological Sciences from Nanyang Technological University and a Master’s and Bachelor’s in Biotechnology from Warsaw University of Technology, complemented by research experiences at notable institutions such as Princeton University and UCL.